The country’s first Covid-19 mRNA vaccine is awaiting a green light from the ministry to be included in the vaccination campaign. The vaccine was approved by the Drug Controller General of India (DCGI) in June.
A government official said the addressable market would now be for booster shots, as most people eligible for Covid-19 vaccines have already received both doses.
“Gennova Biopharmaceuticals and Bharat Biotech also conducted trials of their new vaccines as boosters. It’s best to position any new vaccine now as a precautionary dose,” one of the previously quoted people told ET. “Most people have already taken their first doses.”
The National Technical Advisory Group on Immunization (NTAGI) will meet next week to assess data for inclusion of Bharat Biotech’s nasal vaccine in the national immunization programme. But its inclusion in the vaccination campaign will be decided by the Ministry of Health.
Once a vaccine has received approval from the DCGI, the advisory group, NTAGI, reviews the data and recommends to the Ministry of Health “that it is fit for use”. The department then takes the next call.